Is Enliven Therapeutics, Inc. (ELVN) a Buy, Sell, or Hold?
Enliven Therapeutics, Inc.
NASDAQ:ELVN
$53.16 USD
$1.43 (2.76%)
- Volume
- 495.49K
- Average Volume
- 1.33M
- Market Capitalization
- $3.8B
- P/E Ratio
- -32.41
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $53.24
- Year Low
- $14.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $40.32
ELVN vs. The Competition
| Properties | ELVN | ATAI | DNTH | IMTX |
|---|---|---|---|---|
| Market Cap | $3.8B | $1.97B | $4.17B | $1.27B |
| Shares Outstanding | $71.44M | $368.17M | $41.75M | $134.1M |
| P/E Ratio | -32.41 | -1.79 | -908.27 | -4.83 |
| EPS | -1.57 | -2.93 | -0.24 | -1.59 |
| Day Low | 51.105 | 5.3 | 98.1001 | 9.23 |
| Day high | 53.2 | 5.76 | 102.35 | 9.545 |
| Year Low | 14.785 | 2.59 | 18.08 | 5.05 |
| Year High | 53.24 | 6.75 | 102.37 | 12.41 |
| Average Price 50 | 43.4656 | 4.4141 | 88.275 | 10.2996 |
| Average Price 200 | 30.66295 | 4.30175 | 62.2481 | 10.0922 |
| Volume | 495.49K | 6.14M | 745.75K | 455.72K |
| Average Volume | - | - | - | - |